[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-01-12-10":3},{"date":4,"filings":5,"has_more":86,"limit":87,"page":88,"total_count":89},"2026-01-12",[6,14,22,29,36,43,50,57,61,68,72,79],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Hinduja Global Solutions Ltd","2026-01-12T09:38:22.912000","BSE","HGS Launches AMLens: AI-Powered Anti-Money Laundering Investigation Tool","6964740a5db66db8d2b1b591","HGS","• New product \"AMLens\" uses explainable AI to accelerate anti-money laundering (AML) investigations\n• Designed to help financial institutions streamline compliance processes and reduce false positives\n• Strategic move positions HGS in the growing financial compliance technology market\n• Leverages advanced AI capabilities while maintaining regulatory compliance through explainability features\n• Likely to strengthen HGS's market position in financial services technology solutions\n• Potential revenue growth through new client acquisition in banking and financial services sectors",{"company_name":15,"filing_date":16,"filing_source":17,"headline":18,"id":19,"stock_code":20,"summary_text":21},"Man Industries (India) Limited","2026-01-12T09:13:22.977000","NSE","Man Industries Secures ₹550 Crore Pipe Supply Order","69646defc22bcba1b39f0b1b","MANINDS","• Company has bagged new domestic and international orders worth approximately ₹550 crores\n• Orders are for supply of various types of pipes to domestic\u002Finternational customers\n• Execution timeline is within 6 months from receipt date (January 10, 2026)\n• These orders are part of the company's ordinary course of business\n• The orders do not involve any related party transactions or promoter group interests",{"company_name":23,"filing_date":24,"filing_source":9,"headline":25,"id":26,"stock_code":27,"summary_text":28},"Shree Karthik Papers Ltd","2026-01-12T09:13:22.910000","Promoters Confirm Zero Share Encumbrance for Q4 2025","69646e36c22bcba1b39f0b1d","516106","• Promoters hold 1,42,41,700 equity shares representing 74.52% of the company\n• No encumbrance or pledge made during quarter ended December 31, 2025\n• Zero shares (nil) currently encumbered or pledged by promoters\n• Disclosure made in compliance with SEBI Regulation 31(4)",{"company_name":30,"filing_date":31,"filing_source":9,"headline":32,"id":33,"stock_code":34,"summary_text":35},"Calcom Vision Ltd","2026-01-12T09:08:22.881000","Submission of Quarterly Certificate under SEBI Regulation 74(5) for Q3 2025","69646d06c22bcba1b39f0b18","517236","• Company has submitted compliance certificate for quarter ended December 31, 2025\n• Certificate confirms proper processing of securities received for dematerialization\n• Abhipra Capital Limited (RTA) has verified that securities were accepted\u002Frejected to depositories\n• Dematerialized security certificates were mutilated and canceled after verification\n• Names of depositories substituted in register of members within regulatory timeframe of 15 days\n• Filing made in compliance with SEBI (Depositories and Participants) Regulations, 2018",{"company_name":37,"filing_date":38,"filing_source":17,"headline":39,"id":40,"stock_code":41,"summary_text":42},"Seamec Limited","2026-01-12T09:03:22.972000","SEAMEC PALADIN Vessel Temporarily Off-Hired for Statutory Drydocking","69646bf645b06e73b09f08d2","SEAMECLTD","• Vessel SEAMEC PALADIN has been temporarily off-hired effective January 10, 2026\n• The vessel will undergo statutory drydocking for approximately 70 days\n• This maintenance period represents standard regulatory compliance requirements\n• Temporary unavailability may impact short-term revenue generation capacity\n• Regular maintenance ensures vessel safety and operational efficiency for future contracts",{"company_name":44,"filing_date":45,"filing_source":9,"headline":46,"id":47,"stock_code":48,"summary_text":49},"Kotak Mahindra Bank Ltd","2026-01-12T08:58:22.760000","Appointment of Anup Kumar Saha as Whole-time Director (Executive Director)","69646ac9978a56336afaae0d","KOTAKBANK","• Mr. Anup Kumar Saha (DIN: 07640220) appointed as Additional Director and Whole-time Director (Executive Director) for 3 years, pending RBI approval\n• Effective January 12, 2026, he will serve as Whole-time Director (Designate) and Senior Management Personnel until regulatory approvals\n• Brings 32 years of experience, including 25 years in financial services\n• Previously served as Managing Director & CEO at Bajaj Finance Limited\n• Held senior roles at ICICI Bank for 14 years before Bajaj Finance\n• Will become a Key Managerial Personnel once appointment takes effect",{"company_name":51,"filing_date":52,"filing_source":9,"headline":53,"id":54,"stock_code":55,"summary_text":56},"TANFAC Industries Ltd","2026-01-12T08:53:22.773000","TANFAC Signs ₹2,362.5 Crore Contract with Japanese Customer for Fluorinated Chemicals","6964699d978a56336afaae07","506854","• TANFAC has secured a 7-year contract with a Japanese customer for supply of Fluorinated Chemicals\n• Contract involves supply of 7,500 MT of Fluorinated Chemicals annually\n• Estimated value of ₹337.5 Crores per annum, totaling ₹2,362.5 Crores over the contract period\n• Contract execution period: 7 years starting from January 1, 2027\n• Supply will be for both domestic and export markets\n• The contract was signed in the normal course of business and is not a related party transaction",{"company_name":51,"filing_date":52,"filing_source":9,"headline":58,"id":59,"stock_code":55,"summary_text":60},"Major Contract Win: TANFAC Signs ₹2,362.5 Crore Supply Agreement with Japanese Customer","6964699e5db66db8d2b1b577","• TANFAC has secured a significant 7-year contract with a Japanese customer for supply of Fluorinated Chemicals\n• Contract value: ₹337.5 crores per annum, totaling ₹2,362.5 crores over the full term (exclusive of GST)\n• Supply volume: 7,500 MT of Fluorinated Chemicals\n• Contract execution period: 7 years starting from January 1, 2027\n• The agreement includes both domestic and export supply arrangements\n• This is not a related party transaction and no promoter\u002Fpromoter group has interest in the Japanese customer",{"company_name":62,"filing_date":63,"filing_source":9,"headline":64,"id":65,"stock_code":66,"summary_text":67},"Shakti Pumps India Ltd","2026-01-12T08:43:23.305000","Secures ₹654.03 Crore Order for Solar Water Pumping Systems Under PM-KUSUM Scheme","6964674ad0a2a71a91b1b342","SHAKTIPUMP","• Received first letter of award from Karnataka Renewable Energy Development Limited\n• Contract covers 16,780 Stand-alone Off-Grid DC Solar Photovoltaic Water Pumping Systems\n• Total contract value: ₹600.58 Crores (₹654.03 Crores including GST)\n• Systems to be deployed across the entire state of Karnataka under Component-B of PM-KUSUM scheme\n• Project completion timeline: On or before March 31, 2026",{"company_name":62,"filing_date":63,"filing_source":9,"headline":69,"id":70,"stock_code":66,"summary_text":71},"Shakti Pumps Secures ₹654 Crore Order for Solar Water Pumping Systems Under PM-KUSUM Scheme","6964674b37942f7f23dd96c3","• Received first letter of award from Karnataka Renewable Energy Development Limited for 16,780 Stand-alone Off-Grid DC Solar Photovoltaic Water Pumping Systems\n• Contract valued at ₹600.58 Crores (₹654.03 Crores including GST)\n• Project to be completed on or before March 31, 2026\n• Systems to be designed, manufactured, supplied, transported, installed, tested and commissioned by Shakti Pumps\n• Part of the government's PM-KUSUM scheme to promote solar energy adoption in agriculture",{"company_name":73,"filing_date":74,"filing_source":9,"headline":75,"id":76,"stock_code":77,"summary_text":78},"Biocon Ltd","2026-01-12T08:43:22.752000","Biocon's subsidiary receives FDA approval for Everolimus Tablets for Oral Suspension","696466eb978a56336afaadff","BIOCON","• Biocon Pharma Limited, a wholly owned subsidiary, has secured U.S. FDA approval for its ANDA for Everolimus Tablets\n• The approval covers 2 mg, 3 mg, and 5 mg strengths of the medication\n• The tablets are indicated for treating TSC-related conditions in both adult and pediatric patients\n• This approval will strengthen Biocon's portfolio of vertically integrated drug products\n• The medication treats Subependymal Giant Cell Astrocytoma (SEGA) and TSC-associated partial-onset seizures",{"company_name":80,"filing_date":81,"filing_source":17,"headline":82,"id":83,"stock_code":84,"summary_text":85},"Websol Energy System Limited","2026-01-12T00:08:22.855000","Press Release Notification Filed with Stock Exchanges","6963ee75c22bcba1b39f0a7c","WEBELSOLAR","• Company has submitted a notification to NSE and BSE on January 11, 2026\n• The filing indicates a press release has been enclosed with the notification\n• The company describes the press release as \"self-explanatory\"\n• The document is signed by Raju Sharma, Company Secretary & Compliance Officer\n• The actual content of the press release is not visible in the provided image",false,100,10,912]